Senescent CD8+ T cells: a novel risk factor in atrial fibrillation

Xiang Li,Yangyang Bao,Ning Zhang,Changjian Lin,Yun Xie,Yue Wei,Qingzhi Luo,Jingmeng Liu,Zimo Sha,Guanhua Wu,Taojie Zhou,Qiujing Chen,Tianyou Ling,Wenqi Pan,Lin Lu,Liqun Wu,Yang Dai,Qi Jin
DOI: https://doi.org/10.1093/cvr/cvae222
IF: 13.081
2024-10-11
Cardiovascular Research
Abstract:Immune cell alterations may play a role in the development of atrial fibrillation (AF). Our objective was to comprehensively characterize immune cells in AF, and investigate the potential mechanisms. Single-cell RNA sequencing and multicolor flow cytometry revealed that T cells constituted the most significant subset alterations in AF, and senescent CD8 + T cells were AF-associated subset. Senescent CD8 + T cells increased in both peripheral veins ( p < 0.0001) and the left atria ( p < 0.05) in patients with AF compared to non-AF control. Senescent CD8 + T cells were independently associated with AF prevalence (odds ratio = 2.876, p < 0.05) and postprocedural recurrence (hazard ratio = 22.955, p < 0.0001) using a cross-sectional study and a subsequent prospective cohort study. Senescent CD8 + T cells secreted an increased amount of interferon (IFN)-γ, which induces Ca 2+ handling abnormalities in human induced pluripotent stem cell-derived atrial cardiomyocytes, and translated into an increased susceptibility to AF assessed by heart optical mapping. An increased amount of senescent CD8 + T cells may be a hallmark of the immune senescence phenotype in AF and potentially serve as a valid biomarker for assessing prevalence and postprocedural recurrence of AF. By connecting immune senescence with electrophysiological disturbances in AF, this research provides a potential mechanism for the involvement of senescent CD8 + T cells in proarrhythmic calcium disorders and suggests novel avenues for developing new immune-modulatory and senolytic therapies for AF.
cardiac & cardiovascular systems
What problem does this paper attempt to address?